Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Researchers, Guardians of Trust in Biobank Research?

Published: Monday, February 25, 2013
Last Updated: Monday, February 25, 2013
Bookmark and Share
Do we trust biobank researchers? In his doctoral thesis, Linus Johnsson claims that we do: At least in Sweden. And since we do, researchers in turn have a moral responsibility towards us.

Linus Johnsson, medical doctor and bioethicist at the Centre for Research Ethics & Bioethics (CRB), will defend his thesis on trust in biobank research. Trust is a sensitive issue in all research, but perhaps particularly so when it comes to biobanks. There has been debate on whether the police should be able to access samples, and whether this would lead to distrust and to people withdrawing their samples. In Sweden, the PKU biobank became famous in 2003 after foreign minister Anna Lindh’s murderer was identified through blood stored there.

Public trust in the research community is often measured in surveys. In one study, Linus Johnsson shows that people may be more willing to donate samples than most of these surveys indicate. Especially if health care personnel approach them face-to-face. He believes that this is because relationships of trust are important in our decision making.

In another study, Linus Johnsson found that trust is very much present, at least in the Swedish biobank settings he has studied. According to him, researchers have to consider the expectations that people have of them. The fact that they are trusted in turn means that they have a responsibility towards the public.

Despite ethics review, guidelines and informed consent procedures, ethical issues will always arise during the course of a research project, says Linus Johnsson. He warns against putting too much trust in regulatory systems.

“Relying on formal rules and regulations to guarantee research participants’ trust is not enough. They can never cover all ethical considerations that researchers should make”, he says.

In his thesis, Linus Johnsson sees a danger that the review system fosters researchers to a kind of moral complacency. If we trust the system to take care of everything we risk researchers becoming blind to the ethical issues that are not covered by rules.

“Putting too much trust in the system could potentially alienate researchers to ethics. Following rules is not enough. Researchers and institutions have to reflect on what their duties are”, Linus Johnsson says.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!